During the past decade, Helen Hayes Hospital, Clinical Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helen Hayes Hospital, Clinical Research Center" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Helen Hayes Hospital, Clinical Research Center" are "Osteoporosis" (2 trials). Many other conditions were trialed in "Helen Hayes Hospital, Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Helen Hayes Hospital, Clinical Research Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alendronate" (1 trials), "DP001" (1 trials), "Parathyroid Hormone" (1 trials), "Placebo" (1 trials) and "Teriparatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helen Hayes Hospital, Clinical Research Center" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Helen Hayes Hospital, Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Helen Hayes Hospital, Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helen Hayes Hospital, Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".